ArticleOncology letters2023

Longer interval between neoadjuvant chemoradiotherapy and surgery is associated with improved pathological response, but does not accurately estimate survival in patients with resectable esophageal cancer.

Jiaqi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.